动脉粥样硬化性心血管疾病风险评估中进一步脂质检测与应用  

Advances in detection and application of advanced lipid testing in risk assessment of atherosclerotic cardiovascular disease

作　　者：李江[1] 曹永彤[1] Li Jiang;Cao Yongtong(Department of Clinical Laboratory Medicine,China-Japan Friendship Hospital,Beijing 100089,China)

机构地区：[1]中日友好医院检验科,北京100089

出　　处：《中华检验医学杂志》2021年第7期553-557,共5页Chinese Journal of Laboratory Medicine

基　　金：国家自然科学基金(82072337);北京市临床重点专科项目(2020年度)。

摘　　要：进一步脂质检测是传统标准血脂检测的扩展,已经广泛应用于动脉粥样硬化性心血管疾病(ASCVD)的风险评估和鉴别诊断,尤其是针对诊断不明确和伴有其他代谢风险因素的人群。但测定结果的差异性和溯源问题限制了这些标志物的广泛使用。该文阐述进一步脂质检测在ASCVD风险评估中的临床应用现状、检测技术和检测标准化的进展。Advanced lipid testing is an extension of traditional standard blood lipid testing.These biomarkers have has been widely used in the risk assessment and differential diagnosis of atherosclerotic cardiovascular disease(ASCVD),especially for people with unclear diagnosis and other metabolic risk factors.However,the differences in the measurement results and traceability issues limit the widespread use of these biomarkers.This article aims to introduce and discuss the current status of clinical application of advanced lipid testing in risk assessment of ASCVD,the progress of detection technology and detection standardization in the field.

关 键 词：冠状动脉疾病 进一步脂质检测 标准化 

分 类 号：R54[医药卫生—心血管疾病]